Proteins are important biomolecules, fulfilling tasks in every cell of your body and with a central role in health and disease.

Dr. Harald Weinstabl and Dr. Will Farnaby lead collaboration at Boehringer Ingelheim and the University of Dundee  working on PROTACs, a new class of molecules with the potential to  selectively target and destroy disease-causing proteins.

Drs. Weinstabl and Farnaby's interdisciplinary research team has achieved significant tumor growth inhibition in mice, and this molecule is freely available to other researchers. 

Read their original research: https://doi.org/10.1038/s41467-022-33430-6